Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 42,749 shares at $0.72 ($32K) on 2018-08-31, disclosed to the SEC on 2018-09-05.
Open-market purchase of $32k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.72 | 22,000 | $16K | 50.1% |
| 2 | $0.76 | 20,749 | $16K | 49.9% |
| Total | $0.74 avg | 42,749 | $32K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |